Biotech · Private company
ARCE Therapeutics, Inc.
Track this companyFree. Adds ARCE Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials22 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- ARD103Phase 2 · Acute Myeloid Leukemia, in RelapseClinicalTrials.gov · fetched Nov 12, 2026
- CyclophosphamidePhase 2 · Acute Myeloid Leukemia, in RelapseClinicalTrials.gov · fetched Nov 12, 2026
- FludarabinePhase 2 · Acute Myeloid Leukemia, in RelapseClinicalTrials.gov · fetched Nov 12, 2026
- Non interventional studyAcute Myeloid Leukemia, in RelapseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Long-term Follow-up Study of Patients With ARD103 CAR-T Cell TherapiesRECRUITING · started May 12, 2026ClinicalTrials.gov NCT06906380 · fetched Nov 12, 2026
- Clinical Study of ARD103 CAR-T Therapy for Patients With R/R AML or MDSPHASE1_PHASE2 · RECRUITING · started May 20, 2025ClinicalTrials.gov NCT06680752 · fetched Nov 12, 2026